| |
| |
|
| Insider
Information: |
Chen Jin-Long |
| Relationship: |
Chief Scientific Offic... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
972,893 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,498,255 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
972,893 |
|
|
| Total
Value |
$1,498,255 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ngm Biopharmaceuticals Inc |
NGM |
Chief Scientific Offic... |
2023-03-02 |
972,893 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
64,000 |
972,893 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2023-01-17 |
4 |
S |
$5.15 |
$438,308 |
D/D |
(85,082) |
908,893 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2023-01-17 |
4 |
OE |
$1.44 |
$122,518 |
D/D |
85,082 |
993,975 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2021-12-07 |
4 |
AS |
$18.60 |
$279,000 |
D/D |
(15,000) |
908,893 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2021-12-06 |
4 |
AS |
$18.21 |
$273,150 |
D/D |
(15,000) |
854,449 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2021-12-06 |
4 |
OE |
$1.44 |
$99,999 |
D/D |
69,444 |
923,893 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2021-11-15 |
4 |
AS |
$19.56 |
$591,750 |
D/D |
(30,000) |
869,449 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2021-10-12 |
4 |
AS |
$20.14 |
$302,100 |
D/D |
(15,000) |
899,449 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2021-10-11 |
4 |
AS |
$20.41 |
$306,150 |
D/D |
(15,000) |
914,449 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2021-09-14 |
4 |
AS |
$25.54 |
$384,892 |
D/D |
(15,000) |
929,449 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2021-09-13 |
4 |
AS |
$25.59 |
$390,414 |
D/D |
(15,000) |
944,449 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2021-08-10 |
4 |
AS |
$23.15 |
$347,250 |
D/D |
(15,000) |
959,449 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2021-08-09 |
4 |
AS |
$23.81 |
$366,972 |
D/D |
(15,000) |
974,449 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2021-06-03 |
4 |
OE |
$1.44 |
$99,999 |
D/D |
69,444 |
989,449 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2021-05-03 |
4 |
AS |
$27.62 |
$690,500 |
D/D |
(25,000) |
920,005 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2021-04-12 |
4 |
AS |
$24.65 |
$616,250 |
D/D |
(25,000) |
945,005 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2021-03-01 |
4 |
AS |
$26.66 |
$666,500 |
D/D |
(25,000) |
970,005 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2021-02-16 |
4 |
AS |
$28.75 |
$718,750 |
D/D |
(25,000) |
995,005 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2021-01-05 |
4 |
OE |
$0.60 |
$90,000 |
D/D |
150,000 |
1,020,005 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2021-01-04 |
4 |
AS |
$29.27 |
$732,116 |
D/D |
(25,000) |
870,005 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2020-12-14 |
4 |
AS |
$27.59 |
$700,276 |
D/D |
(25,000) |
895,005 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2020-11-02 |
4 |
AS |
$17.70 |
$442,500 |
D/D |
(25,000) |
920,005 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2020-10-12 |
4 |
AS |
$17.02 |
$425,500 |
D/D |
(25,000) |
945,005 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2020-09-01 |
4 |
AS |
$17.62 |
$445,829 |
D/D |
(25,000) |
970,005 |
0 |
% |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Scientific Officer |
• • – |
2020-08-10 |
4 |
AS |
$19.02 |
$475,500 |
D/D |
(25,000) |
995,005 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
